OakChart

Iradimed Corp

IRMDHealthcare·Medical Devices·USA·Small·NASD·Nov 11 • 3:59 PM ET

86.58-0.14 (-0.16%)
2026-11-12 01:56 CET
Market cap
1,108.99 USD m
Revenue, TTM
89.34 USD m
Net income, TTM
23.98 USD m
Free cash flow, TTM
26.14 USD m
EPS diluted, TTM
1.86
P/E
46.47
Compare

Price

IRMD against its 20, 50 and 200-day averages
2050200beat
80.0090.00100.00166K332KVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26IRMDclose 86.5820-day 85.5550-day 85.34200-day 91.8786.5852w low

19.8% under the 52-week high of 107.90 on 10 Feb 2026. 52-week low 76.35 on 30 Oct 2026. Last 15 sessions, 17.2% high to low

Volume 0.64× normal · the line is the 50-bar volume average

Profile

IRMD
52-week range, 32% of the way up
76.35107.9

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Orlando, FL.

IndexRUT
Employees166
IPOJul 16, 2014
Beta0.91
ATR, 14d3.06
Rel volume0.64
Short float7.08%
Insider own34.85%
Inst own62.50%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.11B
Enterprise Value1.04B
Income23.98M
Sales89.34M
Book/sh8.32
Cash/sh4.95
Dividend Est.-
Dividend TTM0.77 (0.89%)
Dividend Ex-DateNov 13, 2026
Dividend Gr. 3/5Y- -
Payout38.88%
Employees166
IPOJul 16, 2014

Ratios

P/E46.47
Forward P/E35.53
PEG3.09
P/S12.39
P/B10.40
P/C17.49
P/FCF42.36
EV/EBITDA34.20
EV/Sales11.68
Quick Ratio7.68
Current Ratio8.99
Debt/Eq0.00
LT Debt/Eq0.00
Option/ShortYes / Yes

Earnings

EPS (ttm)1.86
EPS next Y2.44
EPS next Q0.59
EPS this Y8.64%
EPS next Y16.22%
EPS next 5Y11.50%
EPS past 3/5Y19.88% 73.89%
Sales past 3/5Y16.28% 21.45%
EPS Y/Y TTM12.65%
Sales Y/Y TTM10.97%
EPS Q/Q16.54%
Sales Q/Q14.15%
EarningsOct 30 BMO
EPS/Sales Surpr.0.00% 3.14%

Ownership

Insider Own34.85%
Insider Trans-0.66%
Inst Own62.50%
Inst Trans-1.66%
ROA20.34%
ROE23.42%
ROIC22.53%
Gross Margin75.51%
Oper. Margin32.30%
Profit Margin26.85%
SMA201.21%
SMA501.45%
SMA200-5.76%
Trades-

Technical

Shs Outstand12.79M
Shs Float8.33M
Short Float7.08%
Short Ratio4.74
Short Interest0.59M
52W High107.90 -19.76%
52W Low76.35 13.40%
Volatility4.95% 3.17%
ATR (14)3.06
RSI (14)52.33
Beta0.91
Rel Volume0.64
Avg Volume124.43K
Volume79,785

Performance

Perf Week-2.26%
Perf Month-3.42%
Perf Quarter-0.67%
Perf Half Y1.54%
Perf YTD-11.00%
Perf Year2.82%
Perf 3Y122.28%
Perf 5Y140.77%
Perf 10Y834.39%
Recom1.67
Target Price118.00
Prev Close86.72
Price86.58
Change %-0.16%

Analyst ratings

latest 9 of 9
DateActionAnalystRating changeTargetImplied
Sep 22, 2026InitiatedNNeedhamHold
Apr 12, 2023InitiatedLLake StreetBuy$50-42.2%
Oct 31, 2017ResumedRROTH CapitalBuy
Oct 05, 2016DowngradeRROTH CapitalBuy → Neutral
Nov 02, 2015ReiteratedRROTH CapitalBuy$25 → $30-65.3%
Jul 30, 2015ReiteratedRROTH CapitalBuy$23 → $25-71.1%
Jun 16, 2015ReiteratedRROTH CapitalBuy$19 → $23-73.4%
Jan 12, 2015ReiteratedRROTH CapitalBuy$15 → $18-79.2%
Dec 23, 2014ReiteratedRROTH CapitalBuy$12 → $15-82.7%

Peers

Mkt cap
TickerCompanyMkt cap
ICUIICU Medical Inc4.46B
INFUInfuSystem Holdings Inc302.10M
BAXBaxter International Inc13.63B
PHGKoninklijke Philips NV ADR29.52B
GEHCGE HealthCare Technologies Inc37.35B
BDXBecton Dickinson & Co58.43B
LMATLemaitre Vascular Inc1.81B
MMSIMerit Medical Systems Inc5.28B
ANGOAngiodynamic Inc522.32M
UTMDUtah Medical Products Inc208.06M

Insider trading

latest 14 of 49
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
ALLEN MONTY KDirectorSep 03 '26Sale86.411,419122,62219,581Sep 08 04:35 PM
Monty K. AllenDirectorSep 03 '26Proposed Sale86.421,419122,624Sep 03 05:13 PM
Scharen-Guivel Hilda FrederiquDirectorJun 04 '26Sale95.003,000285,0005,598Jun 04 04:21 PM
Hilda Scharen-GuivelDirectorJun 04 '26Proposed Sale95.003,000285,000Jun 04 01:00 PM
Susi Roger E.CEO, President, ChairmanJun 01 '26Sale90.602,500226,5072,162,500Jun 02 02:26 PM
Susi Roger E.CEO, President, ChairmanMay 26 '26Sale92.235,000461,1662,167,500May 28 03:08 PM
Susi Roger E.CEO, President, ChairmanMay 27 '26Sale91.952,500229,8782,165,000May 28 03:08 PM
Susi Roger E.CEO, President, ChairmanMay 18 '26Sale87.515,000437,5712,175,000May 20 04:38 PM
Susi Roger E.CEO, President, ChairmanMay 19 '26Sale87.882,500219,6942,172,500May 20 04:38 PM
Susi Roger E.CEO, President, ChairmanMay 12 '26Sale83.924,411370,1832,180,000May 13 04:30 PM
Susi Roger E.CEO, President, ChairmanMay 11 '26Sale84.543,089261,1572,184,411May 13 04:30 PM
Susi Roger E.CEO, President, ChairmanMay 05 '26Sale85.743,750321,5292,187,500May 06 01:51 PM
Susi Roger E.CEO, President, ChairmanMay 04 '26Sale85.693,750321,3332,191,250May 06 01:51 PM
Susi Roger E.CEO, President, ChairmanApr 27 '26Sale89.163,750334,3452,198,750Apr 30 02:30 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
OSCVOpus Small Cap Value Plus ETFAUM: 632.77M
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
DFMCU.S. Micro Cap Portfolio ETF Class SharesAUM: 212.10M
IHIiShares U.S. Medical Devices ETFAUM: 4.07B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-300.5500.5500.51024.2023.473
2026Q22026-07-310.4600.4400.40520.4720.352
2026Q12026-05-010.4900.4450.45221.9821.322
2025Q42026-02-100.5400.4800.50022.6921.602
2025Q32025-11-030.4700.4550.43421.2020.502
2025Q22025-08-010.4900.4350.45020.4120.012
2025Q12025-05-050.4200.4100.36619.5119.332
2024Q42025-02-130.4400.4400.40219.3919.102
2024Q32024-10-310.4300.4050.39518.3318.152
2024Q22024-08-010.4200.3650.38417.9317.652
2024Q12024-05-020.3600.3350.32417.6017.152
2023Q42024-02-080.3900.3800.35617.4517.302
2023Q32023-11-030.4300.3630.39816.5016.183
2023Q22023-08-030.3600.3100.32916.1315.662
2023Q12023-05-040.3000.2830.26915.4814.773
2022Q42023-02-020.3200.3000.29114.8614.902

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY0.8500.7650.78538.5238.54
2020FY0.4000.4400.11031.7231.61
2021FY0.8300.6700.74141.8141.57
2022FY1.1001.0851.01553.3053.30
2023FY1.4801.4751.35165.5665.40
2024FY1.6601.6601.50573.2473.00
2025FY1.9301.8651.75083.8182.70
2026FY-2.097--92.20
2027FY-2.437--102.33
2028FY-2.675--111.05
2029FY-3.040--131.9
2030FY-3.430--145.9

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0230325.3725.0026.10
2026Q4S2026-10-3030225.5725.0026.10
2026Q4S2026-10-1430026.2325.6027.50
2026Q4S2026-09-2131026.2325.6027.50
2026Q4S2026-07-3121025.6025.6025.60
2026Q4S2026-07-1520025.3024.8025.80
2026Q4S2026-05-0621025.3024.8025.80
2026Q4S2026-05-0131025.6324.8026.30
2026Q4S2026-04-2620025.7525.2026.30
2026Q4S2026-02-1021025.7525.2026.30
2026Q4S2026-01-1720024.7524.3025.20
2026Q4S2025-11-1120124.7524.3025.20
2026Q4S2025-11-1020124.7524.3025.20
2026Q4S2025-11-0920124.7524.3025.20

Estimate history

EPS, annual0.040.5210.7850.110.7411.0151.3511.5051.7491.8631
Period201720182019202020212022202320242025TTM
EPS, quarterly0.3950.4020.3660.450.4340.50.4520.4050.505
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual23.08230.43938.51731.71741.81553.30365.56273.24283.81489.34
Period201720182019202020212022202320242025TTM
Sales, quarterly18.32619.38919.51120.40921.20222.69221.97920.46624.203
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual10.59710.98911.76612.30812.54412.59112.6612.7112.78212.788
Period201720182019202020212022202320242025MRQ
Shares, quarterly12.6712.7112.71512.7212.72112.78212.78312.78712.788
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue89.3483.8173.2465.5653.3041.8131.7238.5230.44
Cost of Goods Sold Incl. D&A21.8819.4916.8915.4012.029.768.148.827.21
Gross Profit67.4664.3256.3550.1641.2832.0523.5729.7023.23
Selling, General and Administrative Excl. Other38.6038.1834.3930.1225.6522.2324.3321.0517.22
Research and Development3.292.982.832.862.281.911.901.431.52
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income28.8626.1521.9620.0415.639.82-0.768.656.00
Interest Expense0.000.000.000.000.000.000.00-0.00
Unusual Expense0.000.000.000.000.000.000.00--
Net Income Before Taxes31.1228.3624.2821.7416.189.84-0.629.046.20
Income Taxes7.135.885.044.553.350.51-1.99-0.59-0.11
Consolidated Net Income23.9822.4819.2317.1912.839.331.379.636.30
Net Income From Continuing Operations23.9822.4819.2317.1912.839.331.379.636.30
Net Income23.9822.4819.2317.1912.839.331.379.636.30
EPS (Recurring)1.861.751.501.351.020.740.110.780.52
EPS (Basic, Before Extraordinaries)1.881.771.521.361.020.760.110.850.59
EPS (Diluted)1.861.751.501.351.020.740.110.780.52
EBITDA30.5227.3122.7820.8016.3010.45-0.159.246.56
Non-Operating Income (Expense)2.252.212.311.700.550.020.140.400.19
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.342.311.991.731.101.072.891.351.39
Price To Earnings Ratio46.5546.5537.4736.7326.1758.41203.0427.9244.32
Price To Sales Ratio12.4314.929.609.216.7113.918.947.459.73
Gross Margin75.5176.7576.9476.5077.4576.6574.3377.1176.31
Operating Margin32.3031.2029.9930.5629.3223.48-2.3822.4519.72
Net Margin26.8526.8226.2626.2224.0722.304.3225.0020.71
Shares Outstanding12.7912.7812.7112.6612.5912.5412.3111.7710.99
Market Capitalization1,108.991,108.99693.44595.30339.52533.78261.83248.80250.32

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue24.2020.4721.9822.6921.2020.4119.5119.39
Cost of Goods Sold Incl. D&A5.755.315.175.664.714.454.674.63
Gross Profit18.4615.1616.8117.0316.4915.9514.8414.76
Selling, General and Administrative Excl. Other10.328.779.589.949.669.179.418.96
Research and Development0.880.660.960.800.670.880.620.57
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income8.146.397.247.096.836.795.435.80
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes8.676.897.777.797.307.335.956.34
Income Taxes2.161.671.951.351.721.551.261.20
Consolidated Net Income6.515.225.826.445.585.774.695.15
Net Income From Continuing Operations6.515.225.826.445.585.774.695.15
Net Income6.515.225.826.445.585.774.695.15
EPS (Recurring)0.510.410.450.500.430.450.370.40
EPS (Basic, Before Extraordinaries)0.510.410.460.510.440.450.370.41
EPS (Diluted)0.510.410.450.500.430.450.370.40
EBITDA8.556.807.697.477.227.005.636.00
Non-Operating Income (Expense)0.530.500.530.700.460.540.510.54
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.610.640.540.550.530.580.650.52
Price To Earnings Ratio46.5552.0555.0358.9343.9138.4634.6837.47
Price To Sales Ratio12.4314.2514.3614.9411.379.898.969.62
Gross Margin76.2674.0776.5075.0677.8078.1776.0876.13
Operating Margin33.6331.2332.9331.2632.2333.2627.8429.91
Net Margin26.8825.5026.4728.3926.3028.2924.0226.54
Shares Outstanding12.7912.7912.7812.7812.7212.7212.7212.71
Market Capitalization1,108.991,221.541,230.451,237.52900.48756.31663.84693.44

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments51.1652.2349.7657.9662.5051.9846.2534.3826.34
Short Term Receivables13.6710.5612.2213.275.144.577.294.213.78
Inventories11.6210.4012.825.374.303.933.644.064.21
Other Current Assets4.762.051.190.894.313.251.781.890.78
Total Current Assets81.2075.2476.0077.4976.2463.7458.9644.5435.11
Net Property, Plant & Equipment23.8616.9711.334.614.554.845.011.871.87
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets3.383.102.522.071.120.960.860.830.89
Deferred Tax Assets0.092.822.120.700.771.271.661.090.95
Other Assets0.240.200.180.650.200.260.230.110.20
Total Assets108.7898.3392.1685.5182.8871.0766.7348.4439.01
Short Term Debt Incl. Current Port. of LT Debt0.000.150.430.290.280.260.240.000.00
Accounts Payable1.821.901.861.800.780.660.990.770.66
Income Tax Payable1.810.160.350.120.140.10-0.000.01
Other Current Liabilities6.556.3013.696.345.623.904.623.923.41
Total Current Liabilities10.188.5116.338.556.824.925.864.694.08
Long Term Debt0.000.001.621.912.212.462.720.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities3.982.992.791.381.682.312.631.812.00
Total Liabilities14.1611.5120.7411.8410.719.6811.206.506.08
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity94.6286.8271.4273.6772.1761.3855.5241.9532.93
Total Shareholders Equity94.6286.8271.4273.6772.1761.3855.5241.9532.93
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity94.6286.8271.4273.6772.1761.3855.5241.9532.93
Total Liabilities & Stockholders Equity108.7898.3392.1685.5182.8871.0766.7348.4439.01
Book Value Per Share7.406.835.645.855.754.994.723.823.11
Tangible Book Value Per Share7.146.595.445.695.664.914.653.743.02
Full-Time Employees1661601481231101101149583
Price to Book Ratio10.428.317.984.867.524.284.646.004.66
Return on Assets21.7120.2019.3515.2412.121.9916.7214.421.30
Return on Equity24.7824.3123.7017.5913.962.3419.7616.841.54
Return on Invested Capital23.7622.1523.5416.9712.542.1416.5415.031.52
Quick Ratio6.847.623.878.4310.5412.169.448.637.58
Current Ratio7.988.844.659.0611.1812.9610.069.508.61

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income23.9822.4819.2317.1912.839.331.379.636.30
Depreciation1.661.170.820.770.671.411.341.241.11
Other Funds (Non Cash)3.162.922.522.591.541.583.891.921.92
Funds from Operations30.7029.2921.8819.3815.1012.836.9912.209.18
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-3.55-4.343.75-5.91-5.06-1.58-1.17-1.97-1.81
Income Taxes Payable-1.381.960.06-0.02-0.020.04-0.49-0.00-
Cash from Operating Activities27.1524.9525.6213.4710.0411.265.8210.237.38
Capital Expenditures-1.54-8.42-8.82-8.01-1.87-0.74-0.64-0.49-0.26
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00-
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00-
Purchase or Sale of Investments0.000.000.000.000.501.390.883.691.78
Purchase of Investments0.000.000.000.000.000.000.000.00-1.12
Sale Or Maturity of Investments0.000.000.000.000.501.390.883.692.90
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-1.54-8.42-8.82-8.01-1.370.650.253.201.52
Cash Dividends Paid-16.23-15.04-13.68-13.22-12.560.000.000.000.00
Change in Capital Stock0.000.000.030.180.150.621.732.491.24
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.030.180.150.621.732.491.24
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow-2.62-2.56-0.69-0.61-0.29-0.60-1.21-0.47-0.31
Other Financing Activities Uses-2.62-2.56-0.69-0.61-0.29-0.60-1.21-0.47-0.31
Cash from Financing Activities-18.85-17.60-14.34-13.66-12.710.020.522.020.93
Net Change in Cash6.76-1.072.47-8.20-4.0411.936.5915.459.82
Free Cash Flow26.1417.1817.626.029.2210.785.379.867.15
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow112.00583.77178.36--53.9952.7729.1041.44
Deferred Taxes & Investment Tax Credit-2.73-0.70-1.170.060.520.39-0.60-0.14

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments63.2959.0856.3751.1656.5353.00
Short Term Receivables13.6713.1913.4113.6713.8610.92
Inventories13.4912.2611.8811.6211.7311.20
Other Current Assets2.352.194.754.762.802.25
Total Current Assets92.8086.7286.4281.2084.9277.37
Net Property, Plant & Equipment24.0824.2124.2323.8623.7922.94
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets3.413.443.293.383.373.37
Deferred Tax Assets0.520.360.230.092.422.56
Other Assets0.260.240.230.240.210.20
Total Assets121.07114.97114.39108.78114.72106.45
Short Term Debt Incl. Current Port. of LT Debt0.000.000.000.000.000.00
Accounts Payable2.421.852.181.822.331.90
Income Tax Payable0.550.644.331.813.100.32
Other Current Liabilities7.366.675.616.557.376.59
Total Current Liabilities10.329.1612.1210.1812.808.81
Long Term Debt0.000.000.000.000.000.00
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities4.294.063.763.983.573.33
Total Liabilities14.6213.2315.8814.1616.3712.15
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity106.45101.7598.5194.6298.3594.30
Total Shareholders Equity106.45101.7598.5194.6298.3594.30
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity106.45101.7598.5194.6298.3594.30
Total Liabilities & Stockholders Equity121.07114.97114.39108.78114.72106.45
Book Value Per Share8.327.967.717.407.737.41
Tangible Book Value Per Share8.067.697.457.147.477.15
Full-Time Employees---166--
Price to Book Ratio10.4212.4013.0012.5810.008.40
Return on Assets20.3420.8221.8521.7120.2821.04
Return on Equity23.4223.5225.0424.7823.3123.75
Return on Invested Capital6.115.135.916.815.676.12
Quick Ratio7.688.136.156.845.727.51
Current Ratio8.999.467.137.986.648.78

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income6.515.225.826.445.585.77
Depreciation0.410.410.460.380.380.21
Other Funds (Non Cash)0.910.790.740.720.670.76
Funds from Operations7.676.286.889.876.766.87
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.67-0.341.42-3.950.220.87
Income Taxes Payable-0.09-3.692.200.201.40-0.31
Cash from Operating Activities7.005.948.295.926.997.75
Capital Expenditures-0.21-0.44-0.47-0.42-1.26-2.82
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.21-0.44-0.47-0.42-1.26-2.82
Cash Dividends Paid-2.56-2.56-2.56-8.55-2.16-2.16
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.000.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow-0.02-0.23-0.05-2.32-0.03-0.10
Other Financing Activities Uses-0.02-0.23-0.05-2.32-0.03-0.10
Cash from Financing Activities-2.58-2.79-2.61-10.87-2.19-2.26
Net Change in Cash4.212.715.21-5.373.532.66
Free Cash Flow6.875.757.895.635.855.11
Price to Free Cash Flow112.00132.42137.04584.72143.81126.16

Revenue breakdown

Total Surgical & Medical Instruments & Apparatus revenue2024: 73.24M 2025: 83.81M
Non-US2024: 12.64M 2025: 13.26M
United States2024: 60.61M 2025: 70.56M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-307.08%0.6M8.3M125.36K
2026-10-158.05%0.7M8.3M122.38K
2026-09-307.89%0.7M8.3M127.54K
2026-09-158.40%0.7M8.3M126.10K
2026-08-318.37%0.7M8.3M131.44K
2026-08-148.74%0.7M8.3M144.20K
2026-07-318.05%0.7M8.3M138.16K
2026-07-158.47%0.7M8.3M136.04K
2026-06-308.23%0.7M8.3M130.35K
2026-06-158.18%0.7M8.3M120.73K
2026-05-297.84%0.7M8.3M106.78K
2026-05-157.97%0.7M8.3M92.86K
2026-04-306.61%0.5M8.3M85.27K
2026-04-156.54%0.5M8.3M78.84K
2026-03-316.10%0.5M8.2M75.84K
2026-03-136.00%0.5M8.2M75.30K
2026-02-276.34%0.5M8.2M75.63K
2026-02-135.84%0.5M8.2M78.02K
2026-01-305.86%0.5M8.2M80.51K
2026-01-156.18%0.5M7.4M80.69K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call45.0039.5043.900.003.7370.000.000.893-0.6900.025
call50.0034.5038.900.003.2490.000.000.876-0.6700.028
call55.0029.5033.900.002.8070.000.000.858-0.6460.030
call60.0024.5028.900.002.3980.000.000.836-0.6160.033
call65.0019.5023.900.002.0160.000.000.810-0.5800.037
call70.0014.5018.900.001.6530.000.000.778-0.5370.040
call75.009.5013.906.411.2991.000.000.736-0.4850.044
call80.004.509.006.750.9684.000.000.680-0.3980.048
call85.000.504.901.030.7571.000.000.581-0.2850.053
call90.000.004.001.811.0464.000.000.418-0.2960.053
call95.000.000.950.200.6491810.000.198-0.1400.037
call1000.004.900.000.8590.000.000.157-0.1590.032
call1050.004.900.001.0450.000.000.136-0.1740.029
call1100.004.900.001.2130.000.000.121-0.1870.027
call1150.004.900.001.3670.000.000.110-0.1970.025
call1200.004.900.001.5100.000.000.102-0.2060.024
put45.000.004.900.004.8920.000.00-0.107-0.6870.025
put50.000.004.900.004.2930.000.00-0.124-0.6670.028
put55.000.004.900.003.7520.000.00-0.142-0.6420.030
put60.000.004.900.003.2560.000.00-0.164-0.6110.033
put65.000.004.900.002.7930.000.00-0.190-0.5750.037
put70.000.004.900.002.3540.000.00-0.222-0.5320.040
put75.000.004.900.001.9300.000.00-0.264-0.4780.044
put80.000.004.900.001.5090.000.00-0.320-0.3910.048
put85.000.004.902.701.0701.000.00-0.419-0.2770.053
put90.002.006.500.000.8470.000.00-0.571-0.2820.053
put95.006.2011.000.001.0520.000.00-0.802-0.1320.037
put10011.2016.000.001.3040.000.00-0.842-0.1500.032
put10516.2021.000.001.5260.000.00-0.864-0.1650.029
put11021.2026.000.001.7260.000.00-0.879-0.1770.027
put11526.2031.000.001.9080.000.00-0.889-0.1860.025
put12031.2036.000.002.0770.000.00-0.898-0.1950.024

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-3010-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-308-KCurrent report2026-10-30SEC
2026-10-27SCHEDULE 13G/ASEC
2026-09-254Statement of changes in beneficial ownership of securities2026-09-23SEC
2026-09-084Statement of changes in beneficial ownership of securities2026-09-03SEC
2026-09-03144Filing for proposed sale of securities under Rule 144.SEC
2026-08-188-K/A2026-07-31SEC
2026-07-3110-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-318-KCurrent report2026-07-31SEC
2026-07-28SCHEDULE 13GSEC
2026-06-248-KCurrent report2026-06-24SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-20SEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-04144Filing for proposed sale of securities under Rule 144.SEC
2026-06-024Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-05-284Statement of changes in beneficial ownership of securities2026-05-26SEC
2026-05-204Statement of changes in beneficial ownership of securities2026-05-18SEC
2026-05-14SCHEDULE 13G/ASEC
2026-05-134Statement of changes in beneficial ownership of securities2026-05-11SEC
2026-05-064Statement of changes in beneficial ownership of securities2026-05-04SEC
2026-05-0110-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-018-KCurrent report2026-05-01SEC
2026-04-30ARSAnnual report to security holders. 2025-12-31SEC
2026-04-30DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-23SEC
2026-04-304Statement of changes in beneficial ownership of securities2026-04-27SEC
2026-04-224Statement of changes in beneficial ownership of securities2026-04-20SEC
2026-04-154Statement of changes in beneficial ownership of securities2026-04-13SEC
2026-04-074Statement of changes in beneficial ownership of securities2026-04-06SEC
2026-04-014Statement of changes in beneficial ownership of securities2026-03-30SEC
2026-03-254Statement of changes in beneficial ownership of securities2026-03-23SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-0900122.62K1
2026-080000
2026-070000
2026-0600511.51K2
2026-05002.62M8
2026-04002.77M8
2026-03003.72M8
2026-0200100.26K1
2026-01001.99M4
2025-12004.15M7
2025-11002.88M6

Institutional holders

Manager% owned
BlackRock, Inc.7.57%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC3.11%
RENAISSANCE TECHNOLOGIES LLC3.09%
Copeland Capital Management, LLC2.99%
VANGUARD CAPITAL MANAGEMENT LLC2.85%
T. Rowe Price Investment Management, Inc.2.49%
GEODE CAPITAL MANAGEMENT, LLC2.32%
Nine Ten Capital Management LLC2.01%
DIMENSIONAL FUND ADVISORS LP1.81%
STATE STREET CORP1.73%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.07%
iShares Russell 2000 ETF1.70%
Virtus KAR Small-Cap Growth Fund1.07%
T. Rowe Price Small-Cap Value Fund, Inc.0.91%
JNL Multi-Manager Small Cap Growth Fund0.80%
Fidelity Small Cap Index Fund0.72%
VANGUARD EXTENDED MARKET INDEX FUND0.71%
iShares Russell 2000 Growth ETF0.62%
Fidelity Advisor Small Cap Fund0.51%
Calamos Timpani Small Cap Growth Fund0.49%

OakChart. IRMD. Cached 15 minutes.